Search
Two UT Southwestern faculty members inducted into Shine Academy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/shine-academy.html
In recognition of outstanding teaching, the UT System’s Kenneth I. Shine, M.D., Academy of Health Science Education is inducting two UT Southwestern educators as new members during its annual conference in Austin.
UT Southwestern investigators report first analysis of pioneering kidney cancer radiation approach in clinical trial: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/kidney-cancer-radiation.html
A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center’s kidney cancer program.
Distinguishing between two very similar pediatric brain conditions: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/pediatric-brain-conditions.html
Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests.
Swapping alpha cells for beta cells to treat diabetes: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/beta-cells-diabetes.html
Antibodies that convert glucagon-producing cells into insulin-producing ones cure mouse models of the disease
Combo diabetes treatment amplifies effectiveness, improves medication adherence: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/combo-diabetes-treatment.html
A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.
Hibbs honored with Hackerman Award for work on structure and function of receptors in the brain: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/hibbs-hackerman-award.html
UT Southwestern structural biologist and neuroscientist Ryan Hibbs, Ph.D., has received a 2022 Norman Hackerman Award in Chemical Research.
UT Southwestern biochemist Zhijian ‘James’ Chen to receive 2026 Brinster Prize
https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-brinster-prize.html
Zhijian “James” Chen, Ph.D., Professor in the Department of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on innate immunity, has been awarded the 2026 Elaine Redding Brinster Prize in Science or Medicine.
Kenneth Altshuler, M.D., who led UT Southwestern department of psychiatry for 23 years, dies at 91 : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/altshuler-psychiatry.html
Kenneth Altshuler, M.D., a professor emeritus and longtime chair of psychiatry at UT Southwestern who helped to advance mental health causes in Dallas, died Jan. 6. He was 91.
New CEO to lead UTSW’s Clements University Hospital: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-cuh-ceo.html
Traci d’Auguste, M.B.A., M.S.H.A., who has more than two decades of leadership experience in academic medicine, is the new Vice President and Chief Executive Officer of UT Southwestern Medical Center’s William P. Clements Jr. University Hospital (CUH), effective today.
New combination drug therapy offers hope against methamphetamine addiction: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/methamphetamine-addiction.html
A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in The New England Journal of Medicine.